Table 2.
Extent of Double-Blind Exposure (Safety Population)
Placebo (n=157) | Escitalopram (n=155) | |
---|---|---|
Treatment duration, days, mean±SDa | 100.23±66.70 | 96.62±64.13 |
Overall mean dosage in mg/day, mean±SD | — | 14.04±3.5 |
Overall mean dosage in tablets/day, mean±SD | 1.44±0.32 | 1.40±0.35 |
Patient-yearsb | 43.08 | 41.00 |
Treatment duration=last date of double-blind study drug before taper- down–first date of double-blind study drug+1.
Patient-years=total treatment duration in days/365.25.